SARS-CoV-2 immune responses in patients with multiple myeloma and lenalidomide maintenance therapy.
Martac I, Beer SA, Schenk A, Ahmad O, Maier CP, Demirel G, Preuß B, Klein R, Stanger AMP, Besemer B, Hensen L, Lengerke C.
Martac I, et al. Among authors: klein r.
Front Immunol. 2024 Dec 18;15:1510942. doi: 10.3389/fimmu.2024.1510942. eCollection 2024.
Front Immunol. 2024.
PMID: 39744626
Free PMC article.